相关实验视频

Updated: Sep 13, 2025

A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules

A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules

Published on: March 10, 2017

在化学诱导近距离时代的目标不可知细胞查

¹Oncology R&D, AstraZeneca Waltham Massachusetts 02451 USA Meizhong.jin@astrazeneca.com.

RSC medicinal chemistry

|August 4, 2025

概括

目标不可知性查提供了一种新的药物发现方法,特别是对于"无法药物"的目标. 这种方法利用小分子来诱导蛋白质之间的接近,揭示新的治疗机制和潜在的药物候选者.

科学领域:

药物发现药物发现药物发现
化学生物学化学生物学
遗传学遗传学是一个

背景情况:

虽然以目标为中心的药物发现取得了成功,但它面临着局限性.
没有药物可用的无毒药.
目标和不太了解的疾病机制.
目标不可知查已被用于揭示疾病机制,但受到复杂的作用机制解密的阻碍.

研究的目的:

讨论最近在目标不可知查方面的进展,重点关注化学诱导的近距离.
提出一个框架,以优化目标不可知查效率.

主要方法:

通过目标不可知查识别的小分子的最新出版物的审查.
分析化学诱导的近距离在药物发现中的作用.
开发一个针对目标不可知查的一般框架.

主要成果:

小分子可以通过化学诱导的接近引起功能,创造新的蛋白质-蛋白质相互作用和功能增益效应.
这种方法绕过了传统的以目标为中心的方法和基因淘汰的局限性.

结论:

化学诱导的近距离是药物发现的有希望的途径,特别是对于具有挑战性的目标.
对目标不可知选的平衡框架可以增强击中识别和机制解卷.

更多相关视频

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC

Published on: May 10, 2016

Cell Surface Receptor Identification Using Genome-Scale CRISPR/Cas9 Genetic Screens

Cell Surface Receptor Identification Using Genome-Scale CRISPR/Cas9 Genetic Screens

Published on: June 6, 2020

相关概念视频

Mutagenicity and Carcinogenicity

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...